Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions

Central Serous Chorioretinopathy

Interventions

DRUG

Verteporfin

Chronic CSC are receiving one treatment before the observation period.

Trial Locations (1)

RECRUITING

Stavanger University Hospital, Department of Ophthalmology, Stavanger

All Listed Sponsors

lead

Helse Stavanger HF

OTHER_GOV